PMC:7445716 / 75850-76099
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T693 | 84-87 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
| T694 | 212-222 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T686 | 95-97 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
| T687 | 103-105 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
| T688 | 111-113 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
| T689 | 115-117 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
| T690 | 195-196 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T454 | 0-249 | Sentence | denotes | This feature, together with the frequently reported negative nasopharyngeal swab at GBS onset [22, 24, 36, 44, 45, 52] and clinical improvement after IVIG therapy, seems to support the notion of a prominent post-infectious immune-mediated mechanism. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1147 | 61-75 | UBERON:0001728 | denotes | nasopharyngeal |
| T1148 | 150-154 | CHEBI:42098;CHEBI:42098 | denotes | IVIG |
| T1149 | 223-229 | UBERON:0002405 | denotes | immune |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32840686-32749602-63205832 | 94-96 | 32749602 | denotes | [2 |
| 32840686-32558002-63205833 | 98-100 | 32558002 | denotes | 2 |
| 32840686-32753154-63205834 | 102-104 | 32753154 | denotes | 3 |
| 32840686-32503084-63205835 | 106-108 | 32503084 | denotes | 4 |
| 32840686-32638112-63205836 | 110-112 | 32638112 | denotes | 4 |
| 32840686-32302082-63205837 | 114-116 | 32302082 | denotes | 5 |